Casdatifan

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameCasdatifan
Drug Alias NameAB-521AB521
ClassificationSmall molecules
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitors
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsSolid tumoursKidney NeoplasmsLiver Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesArcus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTaiho Pharmaceutical Co LtdExelixis IncArcus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursKidney NeoplasmsLiver Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A